General Atlantic LLC Ginkgo Bioworks Holdings, Inc. Transaction History

General Atlantic LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.73 - $3.74 $27.1 Million - $139 Million	-37,115,837 Reduced 53.45%	32,319,896 $101 Million
Q2 2022 Aug 12, 2022	SELL	$2.2 - $4.2 $47 Million - $89.8 Million	-21,375,081 Reduced 23.54%	69,435,733 $165 Million
Q1 2022 May 16, 2022	SELL	$2.83 - $8.69 $58.7 Million - $180 Million	-20,755,483 Reduced 18.6%	90,810,814 $366 Million
Q4 2021 Feb 11, 2022	SELL	$8.31 - $14.92 $27.6 Million - $49.5 Million	-3,320,555 Reduced 2.89%	111,566,297 $927 Million
Q3 2021 Nov 15, 2021	BUY	$9.15 - $13.28 $1.05 Billion - $1.53 Billion	114,886,852 New	114,886,852 $1.33 Billion

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of General Atlantic LLC, based on Form 13F filings with the SEC.

Stay updated on General Atlantic LLC with notifications on news.